IDO1 and neoplasm: Anurag et al. identified the upregulated genes in endocrine therapy resistant tumours via unbiased genome‐wide profiling analysis and showed that overexpression of the immune checkpoint components IDO1, LAG3 and PD1 was correlated with AI‐resistant proliferation in luminal B tumours.